Home › Atherosclerosis › Pennsylvania › Harrisburg
Atherosclerosis clinical trials in Harrisburg, PA
4 studies for Atherosclerosis are looking for participants at sites in and around Harrisburg (within about 30 miles). Open a study to see who can join and how to contact the study team.
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
RecruitingPhase 3
- Capital Area Research, LLC, Camp Hill · 3 mi away
A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis
RecruitingPhase 2
- Capital Area Research, LLC - Camp Hill, Camp Hill · 3 mi away
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
RecruitingPhase 3
- Capital Area Research LLC, Camp Hill · 3 mi away
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
RecruitingPhase 3
- Research Site, Camp Hill · 3 mi away
About Atherosclerosis
Atherosclerosis is hardening and narrowing of the arteries caused by the buildup of a fatty substance called plaque. Learn about the risks and prevention.
More about Atherosclerosis on MedlinePlus
Atherosclerosis trials in other cities
- Boston, MA10 studies
- Houston, TX10 studies
- Washington, DC9 studies
- Hialeah, FL8 studies
- Orlando, FL8 studies
- Arlington, VA8 studies
- Memphis, TN7 studies
- Dallas, TX7 studies
- Durham, NC7 studies
- Miami, FL7 studies
- Las Vegas, NV7 studies
- Santa Monica, CA6 studies
Other studies in Harrisburg
- Heart Failure14 studies
- Breast Cancer12 studies
- Non-Small Cell Lung Cancer12 studies
- Cardiovascular Disease11 studies
- Lung Cancer9 studies
- Acute Myeloid Leukemia8 studies
- Prostate Cancer8 studies
- Colorectal Cancer7 studies
- Head and Neck Squamous Cell Carcinoma7 studies
- Crohn's Disease6 studies
- High Blood Pressure6 studies
- Neuroblastoma6 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.